 |
Previous Article | Next Article 
The Journal of Neuroscience, January 1, 2003, 23(1):223-229
Expression of Inducible Nitric Oxide Synthase after Focal
Cerebral Ischemia Stimulates Neurogenesis in the Adult Rodent Dentate
Gyrus
Dong Ya
Zhu,
Shu Hong
Liu,
Hong Suo
Sun, and
You Ming
Lu
Department of Physiology and Biophysics, Neuroscience Research
Group, Faculty of Medicine, University of Calgary, Calgary, Canada, T2N
4N1
 |
ABSTRACT |
The generation of new neurons in the adult mammalian
hippocampus is thought to play a role in repairing the brain after
injury. Here, we show that 7 d after focal cerebral ischemia,
newly divided cells in the dentate gyrus of adult rats increased to
approximately sevenfold, compared with sham controls. In the same area,
this enhanced dentate neurogenesis was associated with activation of inducible nitric oxide synthase (iNOS). Inhibition of iNOS by aminoguanidine prevented ischemia-induced neurogenesis in the dentate
gyrus. In null mutant mice lacking the iNOS gene, increased neurogenesis was not observed after focal cerebral ischemia. This study
demonstrates that expression of iNOS is necessary for
ischemia-stimulated cell birth in the dentate gyrus and indicates that
activation of iNOS may provide a possible strategy for functional
recovery from cerebral ischemic insult.
Key words:
neurogenesis; dentate granule neurons; focal
cerebral ischemia; iNOS expression; iNOS activity; RT-PCR; green
fluorescent protein
 |
Introduction |
Several thousand new neurons are
produced each day in the adult hippocampal dentate gyrus (Kaplan and
Hinds, 1977 ; Eriksson et al., 1998 ; Kornack and Rakic, 1999 ). Some of
these new nerve cells are functionally recruited in the dentate gyrus
circuitry and form appropriate synapses with already existing neurons
(Paton and Nottebohm, 1984 ; Cameron and McKay, 2001 ; van Praag et al., 2002 ). It has been suggested that these new neurons play an important role in behavioral plasticity, including learning (Shors et al., 2001 ).
These findings suggest that neurogenesis in the adult dentate gyrus
occurs in response to diverse physiological stimuli, including stress
(Gould et al., 1998 ). The number of proliferating cells is also
increased in the adult rat dentate gyrus after both stroke (Liu et al.,
1998 ; Takagi et al., 1999 ; Jin et al., 2001 ; Kee et al., 2001 ) and
seizures (Bengzon et al., 1997 ). These findings suggest that
neurogenesis in this area of the brain may be a critical element in
brain repair. However, the molecular and cellular events underlying
enhanced cell proliferation after cerebral ischemic stroke are unclear.
A recent study shows that nitric oxide (NO), a short-lived diffusible
molecule produced from arginine by NO synthase (NOS), is involved in
neurogenesis in the adult hippocampus (Zhang et al., 2001 ). Three
distinct members of the NOS family in mammalian cells have been
identified (Alderton et al., 2001 ). Both neuronal NOS (nNOS) and the
endothelial NOS (eNOS) are constitutively expressed in many tissues
(Thomas and Feron, 1997 ), whereas inducible NOS (iNOS) is
usually not expressed in the CNS except in the inflammatory state
(Heneka and Feinstein, 2001 ). Our previous studies in mice demonstrated
that iNOS is induced in the core of focal cerebral ischemia (Zhu et
al., 2002 ), but whether expression of iNOS mediates enhanced
neurogenesis in the dentate gyrus of adult rats after a cerebral
ischemic insult remains unexplored. In the present study, using a
combined pharmacological and genetic approach, we determined that
activation of iNOS in the dentate gyrus fulfills a necessary condition
for it to be considered a mediator of ischemia-induced neurogenesis.
 |
Materials and Methods |
Focal cerebral ischemia. Sprague Dawley rats
(120 ± 10 d old; ~295 ± 20 gm) and 90 ± 5 d old homozygous iNOS-deficient mice (iNOS /
mice; 34 ± 6 gm;
C57/BL/6-NOS2tm1Lau; Jackson Laboratories,
Bar Harbor, ME) and their wild-type littermates of similar genetic
background (C57/BL/6 iNOS+/+ mice; 35 ± 5 gm; Jackson Laboratories) were used in this study. iNOS /
mice showed undetectable levels of iNOS activity (see Fig.
1D). Anesthesia was induced in animals with ketamine
(100 mg/kg, i.p.) and xylazine (5 mg/kg, i.p.). Body temperature was
maintained at 37 ± 0.5°C with heating pads until the animals
had recovered from surgery. Focal cerebral ischemia was induced by
intraluminal middle cerebral artery (MCA) occlusion, as
described previously (Zhu et al., 2002 ). In brief, a 4/0 (for rats) or
8/0 (for mice) surgical nylon monofilament with rounded tip was
introduced into the left internal carotid through the external carotid
stump, advanced 20-21 mm (in rats) or 16-17 mm (in mice) past the
carotid bifurcation. The filament was left in place for 90 min and then withdrawn. The sham-operated animals were treated identically, except
that the MCAs were not occluded after the neck incision. The infarct
volume was determined in both
iNOS /
and iNOS+/+ mice from the experiments with
sham operation or ischemia, as described previously (Zhu et al., 2002 ).
In brief, brains were removed rapidly and frozen at 20°C for 5 min.
Coronal slices were made at 1-2 mm from the frontal tips, and sections
were immersed in 2% 2,3,5-triphenyltetrazolium chloride (TTC) at
37°C for 20 min. The presence or absence of infarctions was
determined by examining TTC-stained sections for the areas that did not
stain with TTC. The infarct size was expressed as the percentage of the
coronal section area.
RNA extraction and reverse transcription-PCR. Total RNA was
extracted from the dentate gyrus of rats that either suffered focal
cerebral ischemic insult or sham operation (control) using Trizol
reagent according to the manufacturer's instructions
(Sigma, St. Louis, MO). The primers for iNOS reverse transcription
(RT)-PCR were as follows: forward, 5'-CTGCATGGAACAGTATAAGGCAAAC-3';
reverse, 5'-CAGACAGTTTCTGGTCGATGTCATGA-3'. PCR conditions were 35 cycles of denaturation at 95°C for 30 sec, annealing at 63°C for 45 sec, and extension at 72°C for 45 sec. A 40 bp smaller internal iNOS standard was included in the PCR mixture as an iNOS internal standard. PCR products were separated by electrophoresis through 2% agarose containing 0.5 µg/ml ethidium bromide and imaged using a BioDoc-IT imaging system (Bio-Rad, Hercules, CA); band intensities were determined using GS-710 calibrated imaging Densitometer (Bio-Rad). The
ratio of the iNOS mRNA and its internal standard was calculated.
Immunoprecipitation and iNOS activity assay. The dentate
gyrus of rats that suffered either ischemic insult or the sham
operation was microdissected as described previously (Lu et al., 1998 )
and homogenized in ice-cold lysis buffer containing 50 mM tris-HCl, pH 7.6, 150 mM
NaCl, 1% NP-40, 2 mM EDTA, 1 mM sodium orthovanadate, and proteinase inhibitor
mixture (Sigma; 5 µl/100 mg tissue). After debris was cleared by
centrifuging at 14,000 × g at 4°C, protein
concentration in the extracts was determined by Bradford assay
(Bio-Rad). The extracts (~500 µg protein) were incubated with
polyclonal mouse anti-iNOS (2 µg; PharMingen, San Diego, CA)
overnight at 4°C, followed by the addition of 40 µl of Protein G-Sepharose (Sigma) for 3 hr at 4°C. Immunoprecipitates were washed four times with lysis buffer and denatured with SDS sample buffer and
separated by 12% SDS-PAGE. Proteins were transferred onto nitrocellulose membranes using a Bio-Rad mini-protein-III wet transfer
unit overnight at 4°C. Transfer membranes were then incubated with
blocking solution (5% nonfat dried milk dissolved in TBST buffer (pH
7.5, 10 mM Tris-HCl, 150 mM
NaCl, and 0.1% Tween 20) for 1 hr at room temperature, washed three
times, and incubated with polyclonal rabbit anti-iNOS (1: 2000; BD
Transduction Laboratories, Lexington, KY) for 1 hr at room temperature.
Membranes were washed three times with TBST buffer and incubated with
the secondary antibodies (1:1000 dilution) for 1 hr followed by washing
four times. Signal detection was performed with an enhanced
chemiluminescence kit (Amersham Biosciences, Arlington Heights, IL).
The band intensities were determined using a GS-710 calibrated imaging
Densitometer (Bio-Rad). The ratio of the iNOS band intensities to the
amount of loading proteins of the immunoprecipitates was calculated. The activity of iNOS was determined by a
[14C]L-arginine
conversion method (Zhu et al., 2002 ). The iNOS activity is defined as
the difference between the EDTA-containing reaction system and the
reaction system containing both EDTA and nonspecific NOS inhibitor
NG-monomethyl-L-arginine (Sigma) at 50 nM. The protein content of the sample was
determined using a total protein kit (Sigma). The iNOS activity (unit)
was expressed as picomoles per milligram of protein per minute (1 U).
BrdU labeling. Animals were treated intraperitoneally with
50 mg/kg 5-bromodeoxyuridine (BrdU; Sigma) two consecutive times at 8 hr intervals 1, 7, 14, and 21 d after ischemia and killed the next day to estimate the number of proliferating cells. In the
experiments of Figure 4, animals were killed 4 weeks after the BrdU
injection to determine the phenotypes of BrdU-labeled cells. In the
experiments with iNOS inhibitor, the rats were injected intraperitoneally with 100 mg/kg aminoguanidine (AG; Sigma) five times
(5 consecutive days) immediately after ischemia. The rats were then
injected with 50 mg/kg BrdU two consecutive times at 8 hr intervals
immediately after the last AG injection. The rats were killed the next
day for BrdU staining.
Immunocytochemistry. BrdU staining has been described
previously (Liu et al., 2002 ). The sections were heated (85°C for 5 min) in antigen unmasking solution (Vector Laboratories, Burlingame, CA), incubated in 2 M HCl (room temperature for
30 min), rinsed in 0.1 M boric acid, pH 8.5, for
10 min, incubated in 1%
H2O2 in PBS for 30 min, and
blocked in 3% normal goat serum/0.3% Triton X-100/0.1% BSA in PBS
(room temperature for 1 hr), followed by incubation with rat monoclonal
anti-BrdU (1:200; Accurate Chemicals, Westbury, NY) at 4°C overnight.
Subsequently, the sections were developed with an ABC kit (Vector). For
double labeling, the sections were incubated with the affinity-purified
second antibody, goat anti-rat Cy3 antibody (1:200; Chemicon,
Temecula, CA). These sections were then incubated in mouse
anti-NeuN (1:100; Chemicon) and reacted with goat anti-mouse
fluorescein (1:50; Chemicon). For triple staining, the sections were
further incubated with rabbit anti-GFAP (1:1000; Sigma). These sections
were then incubated with goat anti-rabbit Cy5 (1:100; Chemicon).
Sections were rinsed, dried, and coverslipped with Dako (Dako,
Carpinteria, CA) fluorescence mounting medium. Control sections were
processed with omission of the primary antisera. Double or triple
labeling was imaged with a confocal laser scanning microscope (Olympus
LSM-GB200) and analyzed with a three-dimensional (3D) constructor
(Image-Pro Plus software). We produced 3D digital reconstructions from
a series of confocal images taken at 0.5 µm intervals through the region of interest, and optical stacks of 6-12 images were produced for the figures.
Cell counting. An experimenter (D.Y.Z.) coded all slides
from the experiments with sham operation or ischemia before
quantitative analysis. Stereological analysis of total number of
BrdU+ cells in the dentate gyrus was
performed by another experimenter (H.S.S.) who was unaware of the
experimental condition. The analysis was conducted using a modified
version of the optical fractionator method on every sixth
section of peroxide staining tissue. The number of
BrdU+ nuclei in each section was divided
by the area of the dentate gyrus that was determined using
Stereoinvestigator. Double-stained numbers of
BrdU+/NeuN+
and
BrdU+/GFAP+
cells were analyzed by sampling every section from the experimental animals using a fluorescence microscope as described above.
Construction of Semliki Forest Virus-green
fluorescent protein vectors and packaging of the recombinant
virions. Construction of nontoxic virus vectors with a high
infection rate in hippocampal neurons has been described previously
(Liu et al., 2002 ). In brief, the Sacl-Xbal fragment
from Semliki Forest Virus plasmid 1 (pSFV1) (Invitrogen,
Gaithersburg, MD) was subcloned into the
pGEM7Zf+ vector (Promega, Madison, WI). A
PCR-based site-directed mutagenesis was used to change
Ser259 to Pro (p) and
Arg650 to Asp (d) in the nsP2 fragment (pd
mutation). Subsequently, the original fragments in pSFV1 were replaced
by the mutated fragments to obtain pSFV(pd) vectors. Mutations were confirmed by sequencing. A cDNA encoding enhanced green fluorescent (GFP) (Clontech, Cambridge, UK) was then
inserted directly into pSFV(pd) vector to produce
pSFV(pd)-GFP constructs. In vitro
transcribed RNA molecules from pSFV(pd)-GFP were
cotransfected with pSFV-helper2 RNA (a gift from Markus U. Ehrengruber, University of Zurich) into baby hamster kidney cell line
21 (BHK-21) cells. All virus production was performed at 31°C.
Twenty-four hours after electroporation, virus stocks were harvested,
filter sterilized, and activated with Chymotrypsin A4 (Invitrogen). The
reaction was terminated with the trypsin inhibitor aprotinin
(Invitrogen) before use. Final virus titers ( 109 infectious units/ml) were
determined by infection of BHK-21 cells with serial dilutions of virus
stocks, followed by fluorescence microscopy examination at 3 d
after infection.
Activated pSFV(pd)-GFP virus particles (2 µl at
0.2 µl/min) were infused (26 d after the last BrdU injection) into
the left side of the hippocampus with an injection site 2 mm posterior to bregma, 1.5 mm lateral to the midline, and 2 mm below dura. Two days
after infection, animals were fixed under Nembutal anesthesia with 4%
paraformaldehyde in 0.1 M phosphate buffer for
BrdU staining.
 |
Results |
Focal cerebral ischemia increases iNOS mRNA levels and
enzymatic activity
In the adult hippocampal dentate gyrus, there was a low level of
iNOS expression in control animals (Fig.
1A). The iNOS mRNA level in the ipsilateral dentate gyrus began to increase 6 hr (data not
shown) after focal cerebral ischemia and reached a peak 2 d later
(Fig. 1A). Semiquantitative PCR analysis showed that the peak level of iNOS mRNA in the ipsilateral dentate gyrus of the
ischemic rats was increased by ~2.6-fold, compared with sham controls
(Fig. 1A). Increased iNOS mRNA expression remained
elevated for 3 d and then declined to control level 4 d
later. In agreement with the mRNA results, increased iNOS protein
content in the ipsilateral dentate gyrus of the ischemic rats was also
observed (Fig. 1B). Consistent with this increase of
iNOS expression, the enzymatic activity of iNOS was also stimulated.
Thus, 2 d after ischemia, L-arginine
conversion to NO in the ipsilateral dentate gyrus was 6.48 ± 0.43 U (Fig. 1C) (mean ± SEM; n = 5 rats),
whereas in the sham control animals, the enzymatic activity of iNOS was
only 1.68 ± 0.11 U (mean ± SEM; n = 4 rats). However, in the contralateral dentate gyrus of these ischemic
rats, neither the iNOS mRNA level nor its enzymatic activity was
changed at any time point, showing that focal cerebral ischemia
upregulates iNOS activity only in the ipsilateral dentate gyrus. To
confirm that enhanced L-arginine conversion was
mediated by iNOS, we used mutant mice that lack the iNOS gene
(iNOS /
mice). In these animals, iNOS mRNA and iNOS protein were not detected,
and 2 d after ischemia, L-arginine
conversion in the ipsilateral dentate gyrus was only 1.46 ± 0.14 U (Fig. 1D) (mean ± SEM, n = 5 mice), compared with 1.32 ± 0.16 U (mean ± SEM;
n = 5; p > 0.1) in sham-operation
iNOS+/+ mice.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 1.
Focal cerebral ischemia induces iNOS expression in
the ipsilateral dentate gyrus. A, iNOS mRNA
(a1) was examined by RT-PCR using RNA samples from the
dentate gyrus of rats after focal cerebral ischemic insult at the
indicated days. Sham-operated rats were used as control
(Ctr). A PCR product 40 bp smaller than the band derived
from the iNOS cDNA was used as iNOS internal standard (20 fg). Similar
results were observed in each of three experiments and are summarized
in a2. B, Immunoprecipitation
(b1) of protein samples from the dentate gyrus of rats
after focal cerebral ischemia at the indicated days with polyclonal
mouse anti-iNOS. Blots were probed with monoclonal rabbit anti-iNOS.
Similar results were observed in each of three experiments and are
summarized in b2. C, Ischemia increases
iNOS activity in the ipsilateral (filled bars) but not
contralateral (open bars) dentate gyrus.
D, NOS activity is not altered after ischemia in the
dentate gyrus of iNOS null mutant mice ( / ). *p < 0.01, compared with controls (two-tail t test).
|
|
Focal cerebral ischemia stimulates cell proliferation
Next, in rats receiving the focal cerebral ischemia, we examined
BrdU incorporation into dentate gyrus neurons. We treated separate
cohorts of rats 1, 7, 14, and 21 d after ischemia with BrdU twice
with an 8 hr interval between injections. The BrdU-treated rats were
killed on the following day to estimate the number of BrdU-positive
(BrdU+) cells. As can be seen (Fig.
2A), the basal level of
BrdU+ cells in the dentate gyrus was
unchanged in the sham controls, or 1 d after focal cerebral
ischemia (Fig. 2B), indicating that the stress of
surgery did not alter cell proliferation. However, the number of
BrdU+ cells increased in the ipsilateral
but not in the contralateral dentate gyrus 3 d after focal
cerebral ischemia and reached a peak 7 d later (Fig.
2C). The number of BrdU+
cells then decreased by day 21, but this number was still greater than
sham control (Fig. 2D). Cell birth returned to the
basal level in the dentate gyrus of rats 4 weeks after ischemia (Fig. 3).

View larger version (151K):
[in this window]
[in a new window]
|
Figure 2.
Ischemia increases cell proliferation in the
ipsilateral dentate gyrus of adult rats. Rats were treated with BrdU
after sham operation (A), or 1 d
(B), 7 d (C), or
21 d (D) after focal cerebral ischemia. The
next day after the BrdU injection, rats were killed, and the
ipsilateral (Ipsi) and contralateral
(Contra) hippocampi were processed for BrdU staining.
Scale bars, 200 µm.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Figure 3.
Time course of cell birth in the dentate gyrus
after focal cerebral ischemia. In this series of the experiments, rats
were treated with BrdU after sham operation (Control;
n = 10), or 1 d (n = 10),
3 d (n = 9), 7 d (n = 11), or 21 d (n = 8) after focal cerebral
ischemia. The next day after the BrdU injection, rats were killed, and
the ipsilateral (filled bars) and contralateral
(open bars) hippocampi were processed for BrdU staining.
Data are mean ± SEM; *p < 0.01 compared with
control (two-tail t test).
|
|
Focal cerebral ischemia increases the number of new neurons
To determine the fate of the BrdU+
cells, we used antibodies against NeuN, a transcription factor that is
expressed in mature neurons. By performing three-dimensional digital
reconstruction, we found that 68% of the
BrdU+ cells in the granule cell layer were
colabeled with NeuN (Fig. 4A,
BrdU+/NeuN+)
and therefore were differentiated neurons. In this series of experiments, animals received BrdU injection 7 d after
ischemia and were killed 4 weeks later. At this time point, the number of BrdU+ cells in the ipsilateral
dentate gyrus after focal cerebral ischemia was approximately threefold
of the sham control (Fig. 4B).

View larger version (113K):
[in this window]
[in a new window]
|
Figure 4.
Neuronal identity of
BrdU+ cells in the dentate gyrus of ischemic rats.
A, Rats were treated with BrdU 7 d after sham
operation or focal cerebral ischemia and killed 4 weeks after the BrdU
injection. The hippocampal sections were double stained with BrdU
(red) and NeuN (green).
Arrows indicate the double-labeling cells.
B, Summarized numbers of
BrdU+/NeuN+ cells.
C, Expression of GFP in the CA1 and dentate gyrus
(DG) neurons with infusion of
pSFV(pd)-GFP infectious vector into the
rat hippocampus. D, The newly generated granule cells
were identified by expressing GFP. Arrow indicates a
GFP+
(green)/BrdU+
(red) double-labeling granule neuron.
E, No colocalization of GFAP with
BrdU+/NeuN+ cells in the granule
cell layer. Arrow indicates a GFAP+
(blue)/BrdU+
(red) double-labeling cell in the hilus. Scale
bars, 30 µm.
|
|
To establish the neuronal identity of these
BrdU+ cells, we developed mutant SFV
(mSFV) vectors to express enhanced into neurons in the hippocampus
(Fig. 4C). We found that a large number of the
BrdU+ cells expressed GFP
(BrdU+/GFP+)
in the granule cell layer that had the morphological characteristics of
a granule cell, i.e., ~20 µm diameter round or oval cell body with
long dendrites extending toward the molecular layer (Fig. 4D). These data provide further evidence that most of
the new cells in the dentate gyrus of rats that received focal cerebral ischemia matured into granule neurons.
Glia cell generation after focal cerebral ischemia
To exclude the possibility that the
BrdU+ cells expressed in the dentate gyrus
were glia cells, we triple stained sections with antibodies to GFAP. We
found that none of the
BrdU+/NeuN+
cells in the granule cell layer of either control or ischemic animals
were labeled with GFAP (Fig. 4E). Most of the
GFAP-stained astrocytes were located in the hilus and not in the
granule cell layer. Semiquantitative analysis showed that the number of
BrdU+ cells in the hilus of the ischemic
rats was not significantly different from that in the control (data not
shown). This contrasts with the granule cell layer in which most
post-ischemic BrdU+ cells survived and
differentiated into mature granule cells.
Inhibition of iNOS prevents ischemia-induced cell birth
Next, we determined whether ischemia-activated iNOS is required
for increased neurogenesis. We therefore treated rats with the iNOS
inhibitor AG for 5 d at 24 hr intervals immediately after the
ischemic insult. Our previous study in mice showed that this treatment
significantly reduced the size of the infarct (Zhu et al., 2002 ). As
can be seen (Fig. 5A), we
observed enhanced iNOS expression in the ipsilateral dentate gyrus in
these animals 3 d after ischemia. In contrast, there was no
increased L-arginine conversion in AG-treated
ischemic rats (Fig. 5B). iNOS activity in the sham control
and AG-treated ischemic rats was 1.37 ± 0.12 U (mean ± SEM;
n = 5) and 1.39 ± 0.16 U (mean ± SEM;
n = 6), respectively. To characterize cell
proliferation in the AG-treated rats, rats were injected with BrdU
immediately after the last AG injection and killed the following day
for BrdU staining. Representative BrdU+
cell nuclei in the ipsilateral dentate gyrus of AG- and vehicle-treated ischemic rats are shown in Figure 6,
A and B. The average number of
BrdU+ cells in the ipsilateral dentate
gyrus of AG-treated ischemic rats was not statistically different from
that in AG-treated sham control rats (Fig. 6C)
(p > 0.01; two-tailed t test).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
AG inhibits iNOS activity. A, AG
did not alter iNOS expression. iNOS mRNA (top) was
examined by RT-PCR using RNA samples, and blots (bottom)
were probed with anti-iNOS. The samples of RNA and the protein were
from the dentate gyrus of AG-treated ischemic rats. Similar results are
observed in each of three experiments. Bar graph shows
iNOS mRNA (filled bars) and iNOS protein (open
bars) in the ipsilateral dentate gyrus of rats
(n = 3 animals in each group). B, AG
inhibits iNOS activity in the ipsilateral dentate gyrus.
*p < 0.01, compared with control (two-tail
t test).
|
|

View larger version (69K):
[in this window]
[in a new window]
|
Figure 6.
Pharmacological inhibition of iNOS prevents
ischemia-induced cell birth. Representatives of the BrdU labeling in
the ipsilateral dentate gyrus of AG- (A), and
vehicle-treated (B) rats that received
sham-operation or focal cerebral ischemia (isc). Scale
bars, 200 µm. C, Bar graph shows the
summarized data of BrdU+ cells in the ipsilateral
dentate gyrus of AG- (filled bars) and vehicle-treated
(open bars) rats receiving sham operation or focal
cerebral ischemia (n = 8 animals in each group).
Data are mean ± SEM; *p < 0.01 compared with
sham-operation control (two-tail t test).
|
|
We also investigated BrdU+ cells in the
dentate gyrus of the
iNOS /
mice. A previous study shows that
iNOS /
mice are resistant to ischemic injury. Consistent with those data, we found that the infarct size in the
iNOS /
mice 2 d after focal cerebral ischemia was only 15 ± 4%,
compared with 36 ± 8% in the
iNOS+/+ mice (Fig.
7A). iNOS
/ mice
showed no increase of BrdU+ cells in the
dentate gyrus after the ischemic insult (Fig.
7B,C). The number of
BrdU+ cells in the dentate gyrus of
iNOS /
and their wild-type littermates is summarized in Figure 7D.
These data confirm that activation of iNOS induced by focal cerebral ischemia is necessary for enhanced cell proliferation in the dentate gyrus.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 7.
Genetic inhibition of iNOS prevents
ischemia-induced neurogenesis. A, The infarct size in
iNOS / mice
(n = 8) and iNOS+/+ mice
(n = 8) 2 d after focal cerebral ischemia.
Data are mean ± SEM; *p < 0.01 compared with
iNOS+/+ mice (two-tail t test).
B, Representatives of BrdU labeling in the dentate gyrus
of ischemic
iNOS / mice
are shown. C, Representatives of BrdU labeling in the
dentate gyrus of ischemic iNOS+/+ mice are shown.
Scale bars, 200 µm. D, The number of
BrdU+ cells in the ipsilateral
(filled bars) and contralateral (open
bars) dentate gyrus of
iNOS /
(n = 10) and iNOS+/+ mice
(n = 10) is summarized. Data are mean ± SEM;
*p < 0.01 compared with control (two-tail
t test).
|
|
 |
Discussion |
In the dentate gyrus of rats challenged with an ischemic insult,
we found that there was a robust expression of iNOS coupled with an
increase in its enzymatic activity. These changes were associated with
increased cell proliferation in the dentate gyrus. We further showed
that inhibition of endogenous iNOS by the iNOS inhibitor AG prevented
the ischemia-induced increase in neurogenesis. Consistent with this
finding are our data showing that ischemia in iNOS null mutant mice
resulted in significantly fewer BrdU+
cells in the dentate gyrus, compared with their wild-type ischemic littermates. Taken together, our data provide the first evidence showing that activation of iNOS is crucial for ischemia-induced neurogenesis.
Our findings of iNOS-dependent neurogenesis are in agreement with a
recent study showing that there are increased
BrdU+ cells in the dentate gyrus of rats
that received a NO donor (Zhang et al., 2001 ). Although NO sometimes
may be associated with deleterious effects in the CNS (Ye et al.,
1996 ), there are many instances in which NO plays a beneficial role,
including synaptic plasticity (Bon et al., 1992 ; Mori et al., 2001 ) and
the formation of learning and memory (Papa et al., 1994 ). Our data show
that activation of iNOS, which would lead to the production of NO, may
contribute to the events that lead to brain repair. Thus, the increased
expression of iNOS in the dentate gyrus (Fig. 1A) was
associated with enhanced cell proliferation (Fig. 2). In keeping with
the beneficial effects of iNOS, we found that activation of iNOS not
only increased the number of proliferating cells but also increased the
number of mature granule neurons (Fig. 4). Because the changes in iNOS
activity in the dentate gyrus preceded cell proliferation induced by
ischemia, we suggest that activation of iNOS is the primary event for
initiating neurogenesis.
There are two constitutive forms of NOS (cNOS) in the CNS (Thomas and
Feron, 1997 ). Because cNOS is still available to provide NO after
inhibition of iNOS, reduced neurogenesis in iNOS-deficient mice may not
be caused simply by a decreased production of NO. Interestingly, our
earlier study showed that the enzymatic activity of cNOS in the
cerebral cortex of mice is decreased after focal cerebral ischemia (Zhu
et al., 2002 ). It is therefore possible that reduction of cNOS activity
induces iNOS expression, thus providing the diffusible messenger, NO,
to stimulate cell proliferating factors in the hippocampus. Consistent
with this hypothesis, a recent study demonstrates that iNOS expression
is suppressed by the basal activity of cNOS under normal circumstances
and that inhibition of cNOS induces iNOS expression in the rat small
intestine (Qu et al., 2001 ). Thus, it will be of importance to
determine whether iNOS-dependent neurogenesis can be induced in the
hippocampus by inhibition of cNOS.
Direct and indirect evidence suggests that brain injury stimulates the
proliferation of endogenous progenitors in the hippocampus (Gould and
Tanapat, 1997 ; Liu et al., 1998 ; Jin et al., 2001 ; Yoshimura et al.,
2001 ). There is precedent for inhibition of iNOS reducing the ischemic
infarct size in mice (Huang et al., 1994; Samdani et al., 1997;
Ashwal et al., 1998; Zhu et al., 2002 ). Thus, it may be
argued that reduced neurogenesis by inhibition of iNOS is caused simply
by a reduced ischemic injury. As such, iNOS expression after focal
cerebral ischemia may be involved directly in neuronal injury but
indirectly in cell proliferation; however, our findings are not
consistent with this interpretation. First, although inhibition of iNOS
by the iNOS inhibitor AG reduced the size of the infarct after focal
cerebral ischemia (Zhu et al., 2002 ), iNOS expression showed no
difference between AG- and vehicle-treated ischemic animals (Fig.
5A). Second, increased numbers of
BrdU+ cells were observed before the
hippocampal injury. For example, the damage to the CA1
neurons occurs 7 d after focal cerebral ischemia (Zhu and Auer,
1995 ; Nakatomi et al., 2002 ), whereas iNOS-dependent cell birth was
observed 4 d before the injury (Fig. 3). Together these data
suggest that iNOS expression in the dentate gyrus after ischemic insult
is independent of infarct size. Thus, expression of iNOS is directly
responsible for enhanced neurogenesis. A further study is required to
investigate the underlying mechanisms for inducing iNOS expression.
The biochemical events underlying ischemia-induced neurogenesis in the
dentate gyrus are thought to involve activation of NMDA
receptors. In support of this notion are the data showing that rats
receiving an NMDA receptor antagonist at the time of ischemia show no
increased neurogenesis in the dentate gyrus (Nei et al., 1996 ;
Arvidsson et al., 2001 ; Bernabeu and Sharp, 2000 ). There are also
extensive data showing that NOS activity in the hippocampus is
stimulated by activation of NMDA receptors (Cardenas et al., 2000 ;
Jander et al., 2000 ). Thus, the most parsimonious explanation of
our findings is that after focal cerebral ischemia, iNOS is
rapidly activated through NMDA receptor-dependent events. We also
stained hippocampal sections with an anti-iNOS antibody and observed
that iNOS was expressed in both neurons and glia cells in the dentate
gyrus after focal cerebral ischemia (data not shown). This finding is
consistent with previous studies (Holta et al., 2001 ) (but see
Iadecola et al., 1997 ). Thus, the expression of iNOS after focal
cerebral ischemia would provide the diffusible messenger NO to
stimulate neural cell proliferating factors.
Consistent with enhanced neurogenesis after ischemia (Liu et al., 1998 ;
Takagi et al., 1999 ; Jin et al., 2001 ; Kee et al., 2001 ) is our
demonstration that there is an approximately threefold increase in the
number of newly generated granule neurons in the ipsilateral dentate
gyrus of ischemic animals compared with sham controls. There could be
some concerns that the BrdU+ cells that we
observed were stained during the process of apoptosis. However, the
BrdU+ neurons that we observed in the
granule cell layer were labeled 4 weeks after the last BrdU injection,
without any observable degeneration. Most of these
BrdU+/GFP+
neurons showed the normal neuronal morphology of mature granule cells
(Fig. 4D). There are limitations using the expression
of marker proteins to identify new neurons. For example, the most often
used antibodies for mitogen-activated protein-2 and turned on after
division/collapsing response-mediated protein/Unc-33-like phosphoprotein-4 also react with astrocytes and oligodendrocytes (Sensenbrenner et al., 1997 ) and are thus inappropriate as specific markers for neurons. To circumvent this limitation, we used mSFV vector
expression of enhanced GFP in the dentate gyrus. In combination with
BrdU staining, we showed in both ischemic rats and mice that the
increased production of new granule neurons requires activation of iNOS
in the dentate gyrus. The hippocampus plays a critical role in the
formation of declarative memory, and declarative memory formation is
impaired in ischemic rats and humans (Squire and Zola-Morgan, 1996 ).
Because cell transplants reduce ischemia-caused memory deficits (Sinden
et al., 1997 ), our study may provide a molecular strategy for
improvement of learning and memory function via increased neurogenesis
in patients suffering from cerebral ischemic stroke.
 |
FOOTNOTES |
Received July 22, 2002; revised Oct. 4, 2002; accepted Oct. 4, 2002.
This work was supported by grants from the Canadian Institute for
Health Research (Y.M.L), Heart and Stroke Foundation, Canada (Y.M.L),
Alberta Heritage Foundation for Medical Research (Y.M.L), Canada
Foundation for Innovation (Y.M.L), and Alberta Foundation for
Innovation and Science (Y.M.L). We thank Drs. Ken Lukowiak and Wayne
Giles for critical comments on this manuscript.
Correspondence should be addressed to Dr. You Ming Lu, Department of
Physiology and Biophysics, Neuroscience Research Group, Faculty of
Medicine, University of Calgary, Calgary, Canada, T2N 4N1. E-mail:
luy{at}ucalgary.ca.
 |
References |
-
Alderton WK,
Cooper CE,
Knowles RG
(2001)
Nitric oxide synthases: structure, function and inhibition.
Biochem J
357:593-615[Web of Science][Medline].
-
Arvidsson A,
Kokaia Z,
Lindvall O
(2001)
N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke.
Eur J Neurosci
14:10-18[Web of Science][Medline].
-
Bengzon J,
Kokaia Z,
Elmer E,
Nanobashvili A,
Kokaia M,
Lindvall O
(1997)
Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures.
Proc Natl Acad Sci USA
94:10432-10437[Abstract/Free Full Text].
-
Bernabeu R,
Sharp FR
(2000)
NMDA and AMPA/kainite glutamate receptors modulate dentate gyrus neurogenesis and CA3 synapsin-I in normal and ischemic hippocampus.
J Cereb Blood Flow Metab
20:1669-1680[Web of Science][Medline].
-
Bon C,
Bohme GA,
Doble A,
Stutzmann JM,
Blanchard JC
(1992)
A role for nitric oxide in long-term potentiation.
Eur J Neurosci
4:420-424[Web of Science][Medline].
-
Cameron HA,
McKay RD
(2001)
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus.
J Comp Neurol
435:406-417[Web of Science][Medline].
-
Cardenas A,
Moro MA,
Hurtado O,
Leza JC,
Lorenzo P,
Castrillo A,
Bodelon OG,
Bosca L,
Lizasoain I
(2000)
Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices.
J Neurochem
74:2041-2048[Medline].
-
Eriksson PS,
Perfilieva E,
Bjork-Eriksson T,
Alborn AM,
Nordborg C,
Peterson DA,
Gage FH
(1998)
Neurogenesis in the adult human hippocampus.
Nat Med
4:1313-1317[Web of Science][Medline].
-
Gould E,
Tanapat P
(1997)
Lesion-induced proliferation of neuronal progenitors in the dentate gyrus of the adult rat.
Neuroscience
80:427-436[Web of Science][Medline].
-
Gould E,
Tanapat P,
McEwen B,
Flugge G,
Fuchs E
(1998)
Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress.
Proc Natl Acad Sci USA
95:3168-3171[Abstract/Free Full Text].
-
Heneka MT,
Feinstein DL
(2001)
Expression and function of inducible nitric oxide synthase in neurons.
J Neuroimmunol
114:8-18[Web of Science][Medline].
-
Holta ML,
Craddock SD,
Pettigrew C
(2001)
Expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain.
Brain Res
898:49-60[Medline].
-
Iadecola C,
Zhang F,
Cassey R,
Nagayama M,
Ross ME
(1997)
Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.
J Neurosci
17:9157-9164[Abstract/Free Full Text].
-
Jander S,
Schroeter M,
Stoll G
(2000)
Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia.
J Neuroimmunol
109:181-187[Web of Science][Medline].
-
Jin K,
Minami M,
Lan JQ,
Mao XO,
Batteur S,
Simon RP,
Greenberg DA
(2001)
Neurogenesis in dentate subgranular zone and rostral subventricular zone after cerebral ischemia in the rat.
Proc Natl Acad Sci USA
98:4710-4715[Abstract/Free Full Text].
-
Kaplan MS,
Hinds JW
(1977)
Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs.
Science
197:1092-1094[Abstract/Free Full Text].
-
Kee NJ,
Preston E,
Woitowicz JM
(2001)
Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat.
Exp Brain Res
136:313-320[Web of Science][Medline].
-
Kornack DR,
Rakic P
(1999)
Continuation of neurogenesis in the hippocampus of the adult macaque monkey.
Proc Natl Acad Sci USA
96:5768-5773[Abstract/Free Full Text].
-
Liu J,
Solway K,
Messing RO,
Sharp FR
(1998)
Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.
J Neurosci
18:7768-7778[Abstract/Free Full Text].
-
Liu SH,
Wang J,
Zhu DY,
Fu YP,
Lu YM
(2002)
Generation of functional inhibitory neurons in the adult rat hippocampus.
Soc Neurosci Abstr
25:2.
-
Lu YM,
Roder JC,
Davidow J,
Salter MW
(1998)
Src activation in the induction of long-term potentiation in CA1 hippocampal neurons.
Science
279:1363-1367[Abstract/Free Full Text].
-
Mori K,
Togashi H,
Ueno KI,
Matsumoto M,
Yoshioka M
(2001)
Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia.
Behav Brain Res
120:159-168[Medline].
-
Nakatomi H,
Kuriu T,
Okabe S,
Yamamoto S,
Hatano O,
Kawahara N,
Tamura A,
Kirino T,
Nakafuku M
(2002)
Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors.
Cell
110:429-441[Web of Science][Medline].
-
Nei K,
Matsuyama S,
Shuntoh H,
Tanaka C
(1996)
NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus.
Brain Res
728:105-110[Web of Science][Medline].
-
Papa M,
Pellicano MP,
Sadile AG
(1994)
Nitric oxide and long-term habituation to novelty in the rat.
Ann NY Acad Sci
738:316-324[Medline].
-
Paton JA,
Nottebohm F
(1984)
Neurons generated in the adult brain are recruited into functional circuits.
Science
225:1046-1048[Abstract/Free Full Text].
-
Qu XW,
Wang H,
De Plaen IG,
Rozenfeld RA,
Hsueh W
(2001)
Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B.
FASEB J
15:439-446[Abstract/Free Full Text].
-
Sensenbrenner M,
Lucas M,
Deloulme JC
(1997)
Expression of two neuronal markers, growth-associated protein-43 and neuron-specific enolase, in rat glia cells.
J Mol Med
75:653-663[Web of Science][Medline].
-
Squire LR,
Zola-Morgan S
(1996)
Ischemic brain damage and memory impairment: a commentary.
Hippocampus
6:546-552[Web of Science][Medline].
-
Sinden JD,
Rashid-Doubell F,
Kershaw TR,
Nelson A,
Chadwick A,
Jat PS,
Noble MD,
Hodges H,
Gray JA
(1997)
Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischemia-lesioned hippocampus.
Neuroscience
81:599-608[Web of Science][Medline].
-
Shors TJ,
Miesegaes G,
Beylin A,
Zhao M,
Rydel T,
Gould E
(2001)
Neurogenesis in the adult is involved in the formation of trace memories.
Nature
410:372-376[Medline].
-
Takagi Y,
Nozaki K,
Takahashi J,
Yodoi J,
Ishikawa M,
Hashimoto N
(1999)
Proliferation of neuronal precursor cells in the dentate gyrus is accelerated after transient forebrain ischemia in mice.
Brain Res
831:283-287[Web of Science][Medline].
-
Thomas M,
Feron O
(1997)
Nitric oxide synthases: which, where, and why?
J Clin Invest
100:2146-2152[Web of Science][Medline].
-
van Praag H,
Schlinder AF,
Christle BR,
Toni N,
Palmer TD,
Gage FH
(2002)
Functional neurogenesis in the adult hippocampus.
Nature
415:1030-1034[Medline].
-
Ye YZ,
Strong M,
Huang ZQ,
Beckman JS
(1996)
Physiological and pathological processes.
In: Nitric oxide (Packer L,
ed), pp 201-209. New York: Academic.
-
Yoshimura S,
Takagi Y,
Harada J,
Teramoto T,
Thomas SS,
Waeber C,
Bakowska JC,
Breakefield XO,
Moskowitz MA
(2001)
FGF-2 regulation of neurogenesis in adult hippocampus after brain injury.
Proc Natl Acad Sci USA
98:5874-5879[Abstract/Free Full Text].
-
Zhang R,
Zhang L,
Zhang Z,
Wang Y,
Lu M,
Lapointe M,
Chopp M
(2001)
A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats.
Ann Neurol
50:602-611[Web of Science][Medline].
-
Zhu CZ,
Auer RN
(1995)
Graded hypotension and MCA occlusion duration: effect in transient focal ischemia.
J Cereb Blood Flow Metab
15:980-988[Medline].
-
Zhu DY,
Deng Q,
Yao HH,
Wang DC,
Deng Y,
Liu GQ
(2002)
Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient focal cerebral ischemia in mice.
Life Sci
17:1985-1997.
Copyright © 2003 Society for Neuroscience 0270-6474/03/231223-07$05.00/0
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2003 23: 0.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
G. T. Yocum, J. G. Gaudet, S. S. Lee, Y. Stern, L. A. Teverbaugh, R. R. Sciacca, C. W. Emala, D. O. Quest, P. C. McCormick, J. F. McKinsey, et al.
Inducible Nitric Oxide Synthase Promoter Polymorphism Affords Protection Against Cognitive Dysfunction After Carotid Endarterectomy
Stroke,
May 1, 2009;
40(5):
1597 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Deng, D. Glanzman, and J. G. Tidball
Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy
J. Physiol.,
April 15, 2009;
587(8):
1769 - 1778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Korneev, E. I. Korneeva, M. A. Lagarkova, S. L. Kiselev, G. Critchley, and M. O'Shea
Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells
RNA,
October 1, 2008;
14(10):
2030 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg
Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis
J. Pharmacol. Exp. Ther.,
October 1, 2006;
319(1):
150 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ciani, V. Calvanese, C. Crochemore, R. Bartesaghi, and A. Contestabile
Proliferation of cerebellar precursor cells is negatively regulated by nitric oxide in newborn rat
J. Cell Sci.,
August 1, 2006;
119(15):
3161 - 3170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French
Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels
J Neurophysiol,
April 1, 2006;
95(4):
2590 - 2601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Zhang, Z. G. Zhang, and M. Chopp
Neurogenesis in the Adult Ischemic Brain: Generation, Migration, Survival, and Restorative Therapy
Neuroscientist,
October 1, 2005;
11(5):
408 - 416.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Estrada and M. Murillo-Carretero
Nitric Oxide and Adult Neurogenesis in Health and Disease
Neuroscientist,
August 1, 2005;
11(4):
294 - 307.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Chevallier, S. Soriano, D. E. Kang, E. Masliah, G. Hu, and E. H. Koo
Perturbed Neurogenesis in the Adult Hippocampus Associated with Presenilin-1 A246E Mutation
Am. J. Pathol.,
July 1, 2005;
167(1):
151 - 159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Abrous, M. Koehl, and M. Le Moal
Adult Neurogenesis: From Precursors to Network and Physiology
Physiol Rev,
April 1, 2005;
85(2):
523 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Warner, H. Sheng, and I. Batinic-Haberle
Oxidants, antioxidants and the ischemic brain
J. Exp. Biol.,
August 15, 2004;
207(18):
3221 - 3231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-Y. Chyu, P. C Dimayuga, X. Zhao, J. Nilsson, P. K Shah, and B. Cercek
Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells
Vascular Medicine,
August 1, 2004;
9(3):
177 - 183.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Y. Zhu, L. Lau, S. H. Liu, J. S. Wei, and Y. M. Lu
Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus
PNAS,
June 22, 2004;
101(25):
9453 - 9457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Moreno-Lopez, C. Romero-Grimaldi, J. A. Noval, M. Murillo-Carretero, E. R. Matarredona, and C. Estrada
Nitric Oxide Is a Physiological Inhibitor of Neurogenesis in the Adult Mouse Subventricular Zone and Olfactory Bulb
J. Neurosci.,
January 7, 2004;
24(1):
85 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Packer, Y. Stasiv, A. Benraiss, E. Chmielnicki, A. Grinberg, H. Westphal, S. A. Goldman, and G. Enikolopov
Nitric oxide negatively regulates mammalian adult neurogenesis
PNAS,
August 5, 2003;
100(16):
9566 - 9571.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|